Results 41 to 50 of about 12,533 (181)

Comprehensive systematic review summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders [PDF]

open access: yes, 2019
Objective To systematically evaluate the efficacy of treatments for tics and the risks associated with their use. Methods This project followed the methodologies outlined in the 2011 edition of the American Academy of Neurology\u27s guideline development
Cavanna, Andrea E   +12 more
core   +2 more sources

Sexual dysfunction in first-episode schizophrenia patients: results from European First Episode Schizophrenia Trial [PDF]

open access: yes, 2011
Sexual dysfunctions (SDs) occur frequently in schizophrenia patients and have a huge impact on quality of life and compliance. They are often associated with antipsychotic medication.
Fleischhacker, W. Wolfgang   +5 more
core   +1 more source

Potentiometric Assay of Antipsychotic Drug (Ziprasidone Hydrochloride) in Pharmaceuticals, Serum and Urine

open access: yesInternational Journal of Electrochemical Science, 2011
The membranes of ziprasidone hydrochloride-tetraphenyl borate, (Zp-TPB), chlorophenyl borate (Zp-ClPB), phosphotungstate (Zp3-PT), ion associations as molecular recognition reagent dispersed in PVC matrix with dibutylphthalate as plasticizer have been ...
Vinod K. Gupta   +2 more
doaj   +1 more source

Comparative effectiveness of depot and oral second generation antipsychotic drugs in schizophrenia: A nationwide study in Hungary. [PDF]

open access: yes, 2014
We conducted a nationwide, full-population based investigation to evaluate the comparative effectiveness of all marketed second generation antipsychotic drugs (SGA) prescribed for outpatients with the diagnosis of schizophrenia in Hungary.
Bitter   +24 more
core   +1 more source

Ziprasidone use Associated with Sexual Hyperarousal

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
-
Hanife Kocakaya   +4 more
doaj   +1 more source

A 6 week randomized double-blind placebo-controlled trial of ziprasidone for the acute depressive mixed state.

open access: yesPLoS ONE, 2012
ObjectiveTo examine the efficacy of ziprasidone vs. placebo for the depressive mixed state in patients with bipolar disorder type II or major depressive disorder (MDD).Methods73 patients were randomized in a double-blinded, placebo-controlled study to ...
Ashwin Patkar   +14 more
doaj   +1 more source

Влияние луразидона на когнитивное функционирование больных шизофренией: система= тический обзор доказательных исследований препарата

open access: yesСовременная терапия психических расстройств, 2021
В статье выполнен краткий обзор современных представлений о месте когнитивных нарушений в структуре шизофренического процесса, а также о роли атипичных антипсихотиков в вопросе их коррекции.
Оленева, Е.В.
doaj   +1 more source

Psychiatric manifestations of multiple sclerosis and acute disseminated encephalomyelitis [PDF]

open access: yes, 2006
It is unusual for acute disseminated encephalomyelitis and multiple sclerosis to present as purely psychiatric disorders. We report five patients with such demyelinating diseases and symptoms of psychosis, depression or anxiety.
Brinar, Marko   +3 more
core   +1 more source

Systemic medications associate with surgically treated cataract among adults over 50 years in Finland

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To identify associations between systemic drugs and cataract surgery in Finland. Methods A historic cohort study based on administrative data. Endpoint event was cataract surgery. Use of drugs in question was based on redeemed prescriptions and consisted of 156 drugs.
Antti Riikonen   +3 more
wiley   +1 more source

Conventional intramuscular sedatives versus ziprasidone for severe agitation in adolescents: case-control study

open access: yesChild and Adolescent Psychiatry and Mental Health, 2009
Objective The objective of this study was to compare intramuscular (IM) ziprasidone to conventional IM medications (haloperidol combined with lorazepam) for the treatment of severe agitation in adolescents (age 12–17).
Klotz Steven G   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy